The Patient Risk Stratification Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Patient Risk Stratification Market?
The size of the patient risk stratification market has seen substantial growth in recent times. The market size is projected to increase from $2.15 billion in 2024 to $2.82 billion in 2025. The expected compound annual growth rate (CAGR) for this period is 31.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Patient Risk Stratification Industry?
The global market size for patient risk stratification is forecasted to reach $8.30 billion in 2029, with a compound annual growth rate (CAGR) of 31.0%.
Download Your Free Sample of the 2025 Patient Risk Stratification Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Patient Risk Stratification Market?
The key drivers in the patient risk stratification market are:
•Rising middle-class and increased health insurance coverage
•Surge in prevalence of chronic diseases
•Heightened adoption of predictive analytics
•Expanding use of technological advancements including AI and machine learning in healthcare.
Global Market Segmentation: Identifying Major Patient Risk Stratification Industry Segments
The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users
Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Pre-order the 2025 Patient Risk Stratification Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Patient Risk Stratification Market?
The key trends in the patient risk stratification market are:
•Advancements in analytics, artificial intelligence, and machine learning are emerging trends.
•The market is being shaped by ongoing technological advancements and innovative tools.
•The use of wearable technology in patient risk stratification is increasing.
•There is a growing trend towards remote monitoring in healthcare.
Who Are the Top Competitors & Leading Players in the Patient Risk Stratification Market?
Major players in the patient risk stratification market are:
• Bristol-Myers Squibb
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Sales Force Inc.
• Medtronic plc
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Adobe Inc.
• Persistent Systems
• NextGen Healthcare Inc.
• Health Catalyst
• Freenome
• Strive Health
• Medeanalytics Inc.
• American Academy of Family Physicians
• Lightbeam Health Solutions
• Graphnet Health Ltd.
• Innova Medical Group Inc.
• Equipo Health Inc.
• Epic Systems Corporation
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the patient risk stratification market in 2024
